InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Pittman Scott M., Director. Insider active across 1 company, notably Nuo Therapeutics, Inc.. Cumulatively, 6 disclosures have been published. History available since 29 April 2022. The latest transaction was filed on 30 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Scott M. Pittman is a Board Member at Nuo Therapeutics, Inc. He actively participates in strategic discussions at the board level, bringing his experience in management and innovation. His role is essential for the company's development.